Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01442818 · ClinicalTrials.gov registry record · NA
Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery
A NA study, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT01442818 is a NA study that has completed, run by TriHealth. The registered enrollment target is 54 participants.
The verdict
NCT01442818, a NA study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery.
Interventions
- DRUG Dilaudid PCA
- DRUG Dilaudid IV Scheduled
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01442818
The ClinicalTrials.gov registry entry for NCT01442818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dilaudid PCA is the first listed.
NCT01442818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01442818 about?
NCT01442818 is a clinical study titled "Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery". The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery.
What is the current status of trial NCT01442818?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2010-09. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01442818?
The interventions under investigation include: Dilaudid PCA (DRUG), Dilaudid IV Scheduled (DRUG).
Who is sponsoring clinical trial NCT01442818?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.